KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Treasury Shares (2016 - 2025)

Opko Health (OPK) has disclosed Treasury Shares for 16 consecutive years, with $3.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Treasury Shares rose 77.33% year-over-year to $3.2 million, compared with a TTM value of $3.2 million through Dec 2025, up 77.33%, and an annual FY2025 reading of $3.2 million, up 77.33% over the prior year.
  • Treasury Shares was $60.4 million for Q4 2025 at Opko Health, up from $30.2 million in the prior quarter.
  • Across five years, Treasury Shares topped out at $70.0 million in Q3 2024 and bottomed at -$29.8 million in Q1 2025.
  • Average Treasury Shares over 5 years is $10.7 million, with a median of $8.7 million recorded in 2021.
  • The sharpest move saw Treasury Shares changed 0.0% in 2021, then surged 77.33% in 2025.
  • Year by year, Treasury Shares stood at $1.8 million in 2021, then changed by 0.0% to $1.8 million in 2022, then changed by 0.0% to $1.8 million in 2023, then changed by 0.0% to $1.8 million in 2024, then soared by 77.33% to $3.2 million in 2025.
  • Business Quant data shows Treasury Shares for OPK at $3.2 million in Q4 2025, $2.4 million in Q3 2025, and $1.8 million in Q2 2025.